The Company adopted the American Integrity Insurance Group, Inc. 2025 Long-Term Incentive Plan (the “Plan”)

effective May 7, 2025. The Plan has authorized 2,175,758 shares of common stock reserved for issuance under the

During the year ended December 31, 2025, awards granted under the Plan consisted of 7,044 RSAs, which vested

upon grant, and 46,876 RSUs, which remain unvested as of December 31, 2025. Accordingly, a total of 53,920

shares of restricted stock were granted under the Plan during 2025.

At December 31, 2025, there were 2,121,838 shares of Common Stock available for future issuance under the Plan.

On May 7, 2025, in connection with the IPO, the Company issued 652,057 shares of restricted stock to certain

employees and consultants, which vested immediately upon issuance. In connection with the issuance, 234,587

shares were withheld to satisfy the estimated tax withholding and remittance obligations. The shares withheld were

immediately retired and not held as treasury stock, thus, as a result, both the number of shares issued and

outstanding were reduced by the number of shares withheld and retired.

In addition, during 2025, the Company issued restricted stock to its non-employee members of the Board of

Directors in connection with the American Integrity Insurance Group, Inc. 2025 Non-Employee Director

Compensation Policy (the “Non-Employee Director Compensation Policy”) approved on September 9, 2025, under

the Plan. Under the Non-Employee Director Compensation Policy, an initial grant of 2,658 shares of restricted stock

was awarded on September 9, 2025, followed by quarterly grants totaling 4,386 shares as of December 31, 2025.

The shares awarded under this policy vest immediately on their respective grant date.

A summary of all RSA activity for the period May 7, 2025 to December 31, 2025 is as follows:


	Restricted Stock	Weighted Average Grant Date Fair Value
Outstanding, May 7, 2025	—	$—
Granted	659,101	16.05
Shares withheld for tax remittance (retired)	(234,587)	16.00
Vested	(424,514)	16.08
Nonvested at December 31, 2025	—	$—

The Company incurred a one-time share-based compensation expense of $10,433 in connection with the Restricted

Stock Grant and paid $3,753 in taxes in connection with the Restricted Stock Grant Net Settlement related to the

IPO. In addition, during the year ended December 31, 2025, the Company recognized $147 of share-based

compensation expense related to the RSAs granted to the non-employee members of the Board of Directors within

general and administrative expenses in the consolidated statements of operations and comprehensive income.

On December 4, 2025, the Board of Directors approved the grant of 46,876 RSUs in connection with the Company’s

form of RSU agreement (the “RSU Agreement”) under the Plan. The RSUs were granted with a grant-date common

stock fair value of $20.62 per share to certain executive employees. The fair value was determined using the closing

price of our Common Stock reported on the New York Stock Exchange on the grate date. One-third of the total

RSUs granted vest annually on the Plan’s adoption anniversary date over a three-year term. The shares vested under

the RSU Agreement are contingent upon the employee’s continuous employment with the Company through each

A summary of all RSU activity for the period May 7, 2025 to December 31, 2025 is as follows:


	Number of RSUs	Weighted Average Grant Date Fair Value
Granted and unvested at May 7, 2025	—	$—
Granted	46,876	20.62
Vested	—	—
Forfeited	—	—
Granted and unvested at December 31, 2025	46,876	$20.62

The Company recognizes the compensation cost for the RSUs on a straight-line basis over the awards’ vesting

The Company recognized compensation costs associated with the RSUs of $29 for the year ended December 31,

2025. Since the RSUs were authorized for issuance in 2025, there were no compensation costs associated with the